News

Published on 7 Nov 2023 on Benzinga

Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Color...

Article preview image

Gainers

Senti Biosciences, Inc. SNTI shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.

Read the rest of the article
NASDAQ.TMDX price evolution
NASDAQ.NSTG price evolution
NASDAQ.ALTO price evolution
NASDAQ.CHRS price evolution
NYSE.AYX price evolution
NASDAQ.CLOV price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
We Think Some Shareholders May Hesitate To Increase Coherus BioSciences, Inc.'s (NASDAQ:CHRS) CEO...

Key Insights Coherus BioSciences to hold its Annual General Meeting on 29th of MaySalary of US$98...

Simply Wall St. via Yahoo Finance 23 May 2024
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024. CHRS isn't...

Insider Monkey via Yahoo Finance 10 May 2024
When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?

With the business potentially at an important milestone, we thought we'd take a closer look at Co...

Simply Wall St. via Yahoo Finance 8 May 2024
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript March 13, 2024 Coherus B...

Insider Monkey via Yahoo Finance 16 Mar 2024
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...

Net Revenue: Coherus BioSciences Inc (NASDAQ:CHRS) reported a significant increase in net revenue...

GuruFocus.com via Yahoo Finance 13 Mar 2024
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop,...

Key Insights Institutions' substantial holdings in Coherus BioSciences implies that they have sig...

Simply Wall St. via Yahoo Finance 5 Mar 2024
Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be

The latest analyst coverage could presage a bad day for Coherus BioSciences, Inc. (NASDAQ:CHRS), ...

Simply Wall St. via Yahoo Finance 27 Jan 2024
Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody

Shares of Coherus BioSciences, Inc. CHRS were up 23.4% on Dec 27 after the company announced that...

Zacks via Yahoo Finance 28 Dec 2023
Why Coherus BioSciences Stock Is Climbing Today - Coherus BioSciences (NASDAQ:CHRS)

Coherus BioSciences, Inc. CHRS shares are trading higher Wednesday after the company announced th...

Benzinga 27 Dec 2023
Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday’s Pre-Market Session - Bitfarms...

U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 ...

Benzinga 27 Dec 2023

Copyright Statfolio @ 2024

Social Accounts